Mixed lymphocyte cultures from mice with marked differences in major and minor histocompatibility antigens were found to produce an inhibitor of viral replication with properties of interferon. Cultures produced maximal amounts of interferon at approximately 72 to 96 hr, a time when maximal stimulation of deoxyribonucleic acid synthesis also occurred.
There is evidence to indicate that interferon production may be somehow involved in, or at least associated with, the immune recognition mechanisms (2, 3) . Glascow (2) demonstrated an enhanced interferon response by immune leukocytes and Green et al. (3) have recently shown that nonviral antigens may induce interferon production in lymphocyte cultures from sensitized human donors but not in cells from nonsensitized donors. Since the interaction of mixed lymphocyte populations shows many characteristics which have been interpreted as a primary immune reaction to cell surface antigens in vitro, this system was employed to determine whether interferon production results from such cellular interactions.
MATERIALS AND METHODS
Cell cultures. The cell culture conditions employed were those described by Adler et al. (1) . This technique allows long-term viability, transformation, and cell division of mouse lymphoid cells in response to general mitogens and immunologically specific antigens. Adler et al. (J. Immunol., in press) have shown that this culture system also supports mixed cell reactions involving primary stimulus by both major and minor histocompatibility antigens. Mice used in this study were CBA and C57BI/6, since the interaction of these two cell types gave maximal stimulation of deoxyribonucleic acid (DNA) synthesis (W. H. Adler, T. Takiguchi, B. Marsh, and R. T. Smith, J. Immunol., in press). Only one major antigenic determinant, H-25, is shared by these two strains of mice; the other 16 determinants differ. C57B1/6 could conceivably recognize and react to six different antigens on CBA, and CBA to eight on C57B1/6. These two strains presumably differ also at multiple minor histocompatibility loci. Suspensions of mouse spleen cells were prepared by mincing the tissue with scissors and pressing the fragments through a 60-mesh stainlesssteel screen. These fine fragments were then extruded through a 25-gauge needle to produce a suspension of single cells. Cells were washed once with medium, counted, and centrifuged gently; the pellet was suspended in complete medium. Suspensions prepared in this manner usually consisted of 95% mononuclear cells. All cultures were grown in 12-ml screw-capped, disposable plastic tubes containing 3 ml of culture medium and 15 X 106 spleen cells per tube. Two-way mixed lymphocyte cultures contained 7.5 X 106 cells from each of the two strains tested, whereas unmixed control cultures contained 15 X 106 cells from one of the strains. The culture medium consisted of RPMI 1640 (Grand Island Biological Co.) supplemented with 5% fresh human serum, heat-inactivated at 56 C for 30 min. Penicillin and streptomycin were added at 100 units/ml and 100 ,ug/ml, respectively. The cultures were incubated at an angle of 50, loosely capped at 37 C in an atmosphere of 5% CO2 in air and humidity of 80%, for the indicated time. Separate replicate cultures were assayed for either interferon or 3H-thymidine incorporation.
Interferon assays. At the termination of the culture period, cells were sedimented by centrifugation, and the supernatants were assayed for interferon production on mouse L-929 cells. Serial twofold dilutions of the supernatants from the mixed lymphocytes and from the single control (unmixed) cultures, or medium incubated without cells, were made in Eagle's minimal essential medium (MEM) with 10% calf serum. Aliquots (2 ml) were each placed on four well-drained L-cell cultures in 2-oz (60 ml) bottles. After incubation overnight the supernatants were removed, and cultures were challenged with about 200 plaque-forming units (PFU) of vesicular stomatitis virus (VSV). Cultures pretreated with dilutions of the incubated lymphocyte culture medium served as controls. A methyl cellulose overlay was employed consisting of Eagle's MEM with 10% calf serum and 1% methyl cellulose (1,500 centipoises; Fisher Scientific Co.), and the cultures were incubated for 60 to 72 hr. The overlay was then removed, cells were stained with crystal violet, and plaques were enumerated. Per cultures. DNA synthesis was markedly stimulated in the mixed cell cultures beginning at about 48 hr. A small amount of DNA synthesis occurred in the control (unmixed) cultures. Figure 2 shows the results of the interferon assays in replicate cultures. Small amounts of interferon were found in some of the control cultures. The PDD5o units for the control cultures are only approximations, since less than 20% inhibition of VSV plaque formation was found with the largest volume of supernatant tested and the units of interferon had to be estimated by extrapolation. Significant inhibition occurred when the supernatants from mixed cell cultures were assayed. Inhibition was measurable by 67 hr and reached a maximum by 79 to 91 hr. This experiment was repeated three times with similar results.
The activity of the antiviral substance was completely lost upon incubation of the undiluted culture supernatant with trypsin. Crystalline trypsin was added at 500 ,ug/ml at pH 7.5 and incubated for 5 hr at 37 C. Equimolar concentrations of soybean trypsin inhibitor was then added to inhibit further proteolytic activity, and the supernatant was tested without further dilution for interferon activity. The viral inhibitory substance was species specific in that it did not protect chick cells against vaccinia virus or VSV. The viral inhibitory substance was found to be nondialyzable and acid stable. Activity was retained when dialyzed against 40 volumes of basal salt solution or buffer (pH 2) for 24 hr at 4 C. Activity did not sediment at 100,000 x g for 1 hr. In TIME (HOURS (3) . In addition to the well-known effect on viruses, interferon has also been implicated in the inhibition of growth of intracellular parasites such as plasmodia (7, 11) , toxoplasma (9) , and inclusion conjunctivitis agent (5) . Bacterial infections may also be modified by interferon inducers (8, 10, 13 
